CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors

References

• Martinez-Moczygemba M, Huston DP. Biology of common β receptor-signaling cytokines: IL-3, IL-5, and GM-CSF. J Allergy Clin Immunol 2003; 112:653-65; PMID:14564341; http://dx.doi.org/10.1016/j.jaci.2003.08.015
   PubMed Web of Science ®Google Scholar
• Hamelmann E, Gelfand EW. IL-5-induced airway eosinophilia–the key to asthma? Immunol Rev 2001; 179:182-91; PMID:11292022; http://dx.doi.org/10.1034/j.1600-065X.2001.790118.x
   PubMed Web of Science ®Google Scholar
• Dente FL, Carnevali S, Bartoli ML, Cianchetti S, Bacci E, Di Franco A, Vagaggini B, Paggiaro P. Profiles of proinflammatory cytokines in sputum from different groups of severe asthmatic patients. Ann Allergy Asthma Immunol 2006; 97:312-20; PMID:17042136; http://dx.doi.org/10.1016/S1081-1206(10)60795-8
   PubMed Web of Science ®Google Scholar
• Jarjour NN, Erzurum SC, Bleecker ER, Calhoun WJ, Castro M, Comhair SA, Chung KF, Curran-Everett D, Dweik RA, Fain SB, et al. Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program. Am J Respir Crit Care Med 2012; 185:356-62; PMID:22095547; http://dx.doi.org/10.1164/rccm.201107-1317PP
   PubMed Web of Science ®Google Scholar
• Schuijs MJ, Willart MA, Hammad H, Lambrecht BN. Cytokine targets in airway inflammation. Curr Opin Pharmacol 2013; 13:351-61; PMID:23643194; http://dx.doi.org/10.1016/j.coph.2013.03.013
   PubMed Web of Science ®Google Scholar
• Saha S, Doe C, Mistry V, Siddiqui S, Parker D, Sleeman M, Cohen ES, Brightling CE. Granulocyte-macrophage colony-stimulating factor expression in induced sputum and bronchial mucosa in asthma and COPD. Thorax 2009; 64:671-6; PMID:19213775; http://dx.doi.org/10.1136/thx.2008.108290
   PubMed Web of Science ®Google Scholar
• Hoskins A, Roberts JL, 2nd, Milne G, Choi L, Dworski R. Natural-source d-α-tocopheryl acetate inhibits oxidant stress and modulates atopic asthma in humans in vivo. Allergy 2012; 67:676-82; PMID:22435735; http://dx.doi.org/10.1111/j.1398-9995.2012.02810.x
   PubMed Web of Science ®Google Scholar
• Walker C, Bauer W, Braun RK, Menz G, Braun P, Schwarz F, Hansel TT, Villiger B. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med 1994; 150:1038-48; PMID:7921434; http://dx.doi.org/10.1164/ajrccm.150.4.7921434
   PubMed Web of Science ®Google Scholar
• Shi HZ, Xiao CQ, Zhong D, Qin SM, Liu Y, Liang GR, Xu H, Chen YQ, Long XM, Xie ZF. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics. Am J Respir Crit Care Med 1998; 157:204-9; PMID:9445301; http://dx.doi.org/10.1164/ajrccm.157.1.9703027
   PubMed Web of Science ®Google Scholar
• Tavernier J, Van der Heyden J, Verhee A, Brusselle G, Van Ostade X, Vandekerckhove J, North J, Rankin SM, Kay AB, Robinson DS. Interleukin 5 regulates the isoform expression of its own receptor α-subunit. Blood 2000; 95:1600-7; PMID:10688814
   PubMed Web of Science ®Google Scholar
• Sehmi R, Wood LJ, Watson R, Foley R, Hamid Q, O'Byrne PM, Denburg JA. Allergen-induced increases in IL-5 receptor α-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation. J Clin Invest 1997; 100:2466-75; PMID:9366561; http://dx.doi.org/10.1172/JCI119789
   PubMed Web of Science ®Google Scholar
• Hercus TR, Broughton SE, Ekert PG, Ramshaw HS, Perugini M, Grimbaldeston M, Woodcock JM, Thomas D, Pitson S, Hughes T, et al. The GM-CSF receptor family: Mechanism of activation and implications for disease. Growth Factors 2012; 30:63-75; PMID:22257375; http://dx.doi.org/10.3109/08977194.2011.649919
   PubMed Web of Science ®Google Scholar
• Asquith KL, Ramshaw HS, Hansbro PM, Beagley KW, Lopez AF, Foster PS. The IL-3/IL-5/GM-CSF common receptor plays a pivotal role in the regulation of Th2 immunity and allergic airway inflammation. J Immunol 2008; 180:1199-206; PMID:18178860; http://dx.doi.org/10.4049/jimmunol.180.2.1199
   PubMed Web of Science ®Google Scholar
• Trifilieff A, Fujitani Y, Coyle AJ, Kopf M, Bertrand C. IL-5 deficiency abolishes aspects of airway remodelling in a murine model of lung inflammation. Clin Exp Allergy 2001; 31:934-42; PMID:11422160; http://dx.doi.org/10.1046/j.1365-2222.2001.01084.x
   PubMed Web of Science ®Google Scholar
• Pavord ID, Korn S, Howarth P, Bleecker ER, Buhl R, Keene ON, Ortega H, Chanez P. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet 2012; 380:651-9; PMID:22901886; http://dx.doi.org/10.1016/S0140-6736(12)60988-X
   PubMed Web of Science ®Google Scholar
• Ghazi A, Trikha A, Calhoun WJ. Benralizumab-a humanized mAb to IL-5Ralpha with enhanced antibody-dependent cell-mediated cytotoxicity-a novel approach for the treatment of asthma. Expert Opin Biol Ther 2012; 12:113-8; PMID:22136436; http://dx.doi.org/10.1517/14712598.2012.642359
   PubMed Web of Science ®Google Scholar
• Walsh GM. Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma. Biologics 2013; 7:7-11; PMID:23326187
   PubMedGoogle Scholar
• Hamilton JA. GM-CSF as a target in inflammatory/autoimmune disease: current evidence and future therapeutic potential. Expert Rev Clin Immunol 2015; 11:457-65; PMID:25748625; http://dx.doi.org/10.1586/1744666X.2015.1024110
   PubMed Web of Science ®Google Scholar
• Hilvering B, Xue L, Pavord ID. Evidence for the efficacy and safety of anti-interleukin-5 treatment in the management of refractory eosinophilic asthma. Ther Adv Respir Dis 2015; 9:135-45; PMID:25900924; http://dx.doi.org/10.1177/1753465815581279
   PubMed Web of Science ®Google Scholar
• Molfino NA. Targeting of eosinophils in asthma. Expert Opin Biol Ther 2012; 12:807-9; PMID:22500988; http://dx.doi.org/10.1517/14712598.2012.674938
   PubMed Web of Science ®Google Scholar
• Kalobios Pharmaceuticals Inc. KaloBios Reports Top Line Data for Phase 2 Study of KB003 in Severe Asthma. Study Does Not Meet Primary Endpoint. Media release, January 29, 2014 2014:http://www.kalobios.com/.
   Google Scholar
• Ortega HG, Liu MC, Pavord ID, Brusselle GG, FitzGerald JM, Chetta A, Humbert M, Katz LE, Keene ON, Yancey SW, et al. Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med 2014; 371:1198-207; PMID:25199059; http://dx.doi.org/10.1056/NEJMoa1403290
   PubMed Web of Science ®Google Scholar
• Bel EH, Wenzel SE, Thompson PJ, Prazma CM, Keene ON, Yancey SW, Ortega HG, Pavord ID; SIRIUS Investigators. Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma. N Engl J Med 2014; 371:1189-97; PMID:25199060; http://dx.doi.org/10.1056/NEJMoa1403291
   PubMed Web of Science ®Google Scholar
• Nair P. Anti-interleukin-5 monoclonal antibody to treat severe eosinophilic asthma. N Engl J Med 2014; 371:1249-51; PMID:25197762; http://dx.doi.org/10.1056/NEJMe1408614
   PubMed Web of Science ®Google Scholar
• Sun Q, Jones K, McClure B, Cambareri B, Zacharakis B, Iversen PO, Stomski F, Woodcock JM, Bagley CJ, D'Andrea R, et al. Simultaneous antagonism of interleukin-5, granulocyte-macrophage colony-stimulating factor, and interleukin-3 stimulation of human eosinophils by targetting the common cytokine binding site of their receptors. Blood 1999; 94:1943-51; PMID:10477723
   PubMed Web of Science ®Google Scholar
• Wechsler ME, Fulkerson PC, Bochner BS, Gauvreau GM, Gleich GJ, Henkel T, Kolbeck R, Mathur SK, Ortega H, Patel J, et al. Novel targeted therapies for eosinophilic disorders. J Allergy Clin Immunol 2012; 130:563-71; PMID:22935585; http://dx.doi.org/10.1016/j.jaci.2012.07.027
   PubMed Web of Science ®Google Scholar
• Hansen G, Hercus TR, McClure BJ, Stomski FC, Dottore M, Powell J, Ramshaw H, Woodcock JM, Xu Y, Guthridge M, et al. The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation. Cell 2008; 134:496-507; PMID:18692472; http://dx.doi.org/10.1016/j.cell.2008.05.053
   PubMed Web of Science ®Google Scholar
• Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Miyagawa K, Piao YF, Miyazono K, Urabe A, Takaku F. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol 1989; 140:323-34; PMID:2663885; http://dx.doi.org/10.1002/jcp.1041400219
   PubMed Web of Science ®Google Scholar
• Angal S, King DJ, Bodmer MW, Turner A, Lawson AD, Roberts G, Pedley B, Adair JR. A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody. Mol Immunol 1993; 30:105-8; PMID:8417368; http://dx.doi.org/10.1016/0161-5890(93)90432-B
   PubMed Web of Science ®Google Scholar
• Sautina L, Sautin Y, Beem E, Zhou Z, Schuler A, Brennan J, Zharikov SI, Diao Y, Bungert J, Segal MS. Induction of nitric oxide by erythropoietin is mediated by the β common receptor and requires interaction with VEGF receptor 2. Blood 2010; 115:896-905; PMID:19965681; http://dx.doi.org/10.1182/blood-2009-04-216432
   PubMed Web of Science ®Google Scholar
• Wilson IA, Stanfield RL. Antibody-antigen interactions. Curr Op Struct Biol 1993; 3:113-8; http://dx.doi.org/10.1016/0959-440X(93)90210-C
   Web of Science ®Google Scholar
• Lopez AF, Vadas MA, Woodcock JM, Milton SE, Lewis A, Elliott MJ, Gillis D, Ireland R, Olwell E, Park LS. Interleukin-5, interleukin-3, and granulocyte-macrophage colony-stimulating factor cross-compete for binding to cell surface receptors on human eosinophils. J Biol Chem 1991; 266:24741-7; PMID:1761568
   PubMed Web of Science ®Google Scholar
• Hercus TR, Thomas D, Guthridge MA, Ekert PG, King-Scott J, Parker MW, Lopez AF. The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease. Blood 2009; 114:1289-98; PMID:19436055; http://dx.doi.org/10.1182/blood-2008-12-164004
   PubMed Web of Science ®Google Scholar
• Murphy JM, Ford SC, Wiedemann UM, Carr PD, Ollis DL, Young IG. A novel functional epitope formed by domains 1 and 4 of the human common β-subunit is involved in receptor activation by granulocyte macrophage colony-stimulating factor and interleukin 5. J Biol Chem 2003; 278:10572-7; PMID:12525483; http://dx.doi.org/10.1074/jbc.M211664200
   PubMed Web of Science ®Google Scholar
• Scibek JJ, Evergren E, Zahn S, Canziani GA, Van Ryk D, Chaiken IM. Biosensor analysis of dynamics of interleukin 5 receptor subunit β(c) interaction with IL5:IL5R(α) complexes. Anal Biochem 2002; 307:258-65; PMID:12202242; http://dx.doi.org/10.1016/S0003-2697(02)00043-X
   PubMed Web of Science ®Google Scholar
• Murphy JM, Ford SC, Olsen JE, Gustin SE, Jeffrey PD, Ollis DL, Young IG. Interleukin-3 binding to the murine betaIL-3 and human betac receptors involves functional epitopes formed by domains 1 and 4 of different protein chains. J Biol Chem 2004; 279:26500-8; PMID:15060062; http://dx.doi.org/10.1074/jbc.M402705200
   PubMed Web of Science ®Google Scholar
• Woodcock JM, Bagley CJ, Zacharakis B, Lopez AF. A single tyrosine residue in the membrane-proximal domain of the granulocyte-macrophage colony-stimulating factor, interleukin (IL)-3, and IL-5 receptor common β-chain is necessary and sufficient for high affinity binding and signaling by all three ligands. J Biol Chem 1996; 271:25999-6006; PMID:8824238; http://dx.doi.org/10.1074/jbc.271.42.25999
   PubMed Web of Science ®Google Scholar
• Lock P, Metcalf D, Nicola NA. Histidine-367 of the human common β chain of the receptor is critical for high-affinity binding of human granulocyte-macrophage colony-stimulating factor. Proc Natl Acad Sci USA 1994; 91:252-6; PMID:8278375; http://dx.doi.org/10.1073/pnas.91.1.252
   PubMed Web of Science ®Google Scholar
• Woodcock JM, Zacharakis B, Plaetinck G, Bagley CJ, Qiyu S, Hercus TR, Tavernier J, Lopez AF. Three residues in the common β chain of the human GM-CSF, IL-3 and IL-5 receptors are essential for GM-CSF and IL-5 but not IL-3 high affinity binding and interact with Glu21 of GM-CSF. EMBOJ 1994; 13:5176-85.
   PubMed Web of Science ®Google Scholar
• Lawrence MC, Colman PM. Shape complementarity at protein/protein interfaces. J Mol Biol 1993; 234:946-50; PMID:8263940; http://dx.doi.org/10.1006/jmbi.1993.1648
   PubMed Web of Science ®Google Scholar
• Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, Marshall RP, Bradding P, Green RH, Wardlaw AJ, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009; 360:973-84; PMID:19264686; http://dx.doi.org/10.1056/NEJMoa0808991
   PubMed Web of Science ®Google Scholar
• Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, Hargreave FE, O'Byrne PM. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009; 360:985-93; PMID:19264687; http://dx.doi.org/10.1056/NEJMoa0805435
   PubMed Web of Science ®Google Scholar
• Lindemann A, Ganser A, Herrmann F, Frisch J, Seipelt G, Schulz G, Hoelzer D, Mertelsmann R. Biologic effects of recombinant human interleukin-3 in vivo. J Clin Oncol 1991; 9:2120-7; PMID:1960553
   PubMed Web of Science ®Google Scholar
• Nievergall E, Ramshaw HS, Yong AS, Biondo M, Busfield SJ, Vairo G, Lopez AF, Hughes TP, White DL, Hiwase DK. Monoclonal antibody targeting of IL-3 receptor α with CSL362 effectively depletes CML progenitor and stem cells. Blood 2014; 123:1218-28; PMID:24363400; http://dx.doi.org/10.1182/blood-2012-12-475194
   PubMed Web of Science ®Google Scholar
• Burmester GR, Feist E, Sleeman MA, Wang B, White B, Magrini F. Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor-α, in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human study. Ann Rheum Dis 2011; 70:1542-9; PMID:21613310; http://dx.doi.org/10.1136/ard.2010.146225
   PubMed Web of Science ®Google Scholar
• Koike M, Furuya A, Nakamura K, Iida A, Anazawa H, Hanai N, et al. Antibody against human interleukin-5-receptor α chain. United States: US patent 6,018,032, 1997.
   Google Scholar
• Diamant Z, Gauvreau GM, Cockcroft DW, Boulet LP, Sterk PJ, de Jongh FH, Dahlén B, O'Byrne PM. Inhaled allergen bronchoprovocation tests. J Allergy Clin Immunol 2013; 132:1045-55 e6; PMID:24119772; http://dx.doi.org/10.1016/j.jaci.2013.08.023
   PubMed Web of Science ®Google Scholar
• Gauvreau GM, Ellis AK, Denburg JA. Haemopoietic processes in allergic disease: eosinophil/basophil development. Clin Exp Allergy 2009; 39:1297-306; PMID:19622087; http://dx.doi.org/10.1111/j.1365-2222.2009.03325.x
   PubMed Web of Science ®Google Scholar
• Tavernier J, Devos R, Cornelis S, Tuypens T, Van der Heyden J, Fiers W, Plaetinck G. A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific α chain and a β chain shared with the receptor for GM-CSF. Cell 1991; 66:1175-84; PMID:1833065; http://dx.doi.org/10.1016/0092-8674(91)90040-6
   PubMed Web of Science ®Google Scholar
• Hayashida K, Kitamura T, Gorman DM, Arai K, Yokota T, Miyajima A. Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor. Proc Natl Acad Sci USA 1990; 87:9655-9; PMID:1702217; http://dx.doi.org/10.1073/pnas.87.24.9655
   PubMed Web of Science ®Google Scholar
• Kitamura T, Hayashida K, Sakamaki K, Yokota T, Arai K, Miyajima A. Reconstitution of functional receptors for human granulocyte/macrophage colony-stimulating factor (GM-CSF): evidence that the protein encoded by the AIC2B cDNA is a subunit of the murine GM-CSF receptor. Proc Natl Acad Sci USA 1991; 88:5082-6; PMID:1828890; http://dx.doi.org/10.1073/pnas.88.12.5082
   PubMed Web of Science ®Google Scholar
• Kitamura T, Sato N, Arai K, Miyajima A. Expression cloning of the human IL-3 receptor cDNA reveals a shared β subunit for the human IL-3 and GM-CSF receptors. Cell 1991; 66:1165-74; PMID:1833064; http://dx.doi.org/10.1016/0092-8674(91)90039-2
   PubMed Web of Science ®Google Scholar
• Kitamura T, Miyajima A. Functional reconstitution of the human interleukin-3 receptor. Blood 1992; 80:84-90; PMID:1377056
   PubMed Web of Science ®Google Scholar
• Kankaanranta H, Lindsay MA, Giembycz MA, Zhang X, Moilanen E, Barnes PJ. Delayed eosinophil apoptosis in asthma. J Allergy Clin Immunol 2000; 106:77-83; PMID:10887309; http://dx.doi.org/10.1067/mai.2000.107038
   PubMed Web of Science ®Google Scholar
• Moore WC, Fitzpatrick AM, Li X, Hastie AT, Li H, Meyers DA, Bleecker ER. Clinical heterogeneity in the severe asthma research program. Ann Am Thorac Soc 2013; 10 Suppl:S118-24; PMID:24313761; http://dx.doi.org/10.1513/AnnalsATS.201309-307AW
   PubMedGoogle Scholar
• Sehmi R, Baatjes AJ, Denburg JA. Hemopoietic progenitor cells and hemopoietic factors: potential targets for treatment of allergic inflammatory diseases. Curr Drug Targets Inflamm Allergy 2003; 2:271-8; PMID:14561146; http://dx.doi.org/10.2174/1568010033484007
   PubMedGoogle Scholar
• Menzies-Gow A, Flood-Page P, Sehmi R, Burman J, Hamid Q, Robinson DS, Kay AB, Denburg J. Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics. J Allergy Clin Immunol 2003; 111:714-9; PMID:12704348; http://dx.doi.org/10.1067/mai.2003.1382
   PubMed Web of Science ®Google Scholar
• Liu LY, Sedgwick JB, Bates ME, Vrtis RF, Gern JE, Kita H, Jarjour NN, Busse WW, Kelly EA. Decreased expression of membrane IL-5 receptor α on human eosinophils: II. IL-5 down-modulates its receptor via a proteinase-mediated process. J Immunol 2002; 169:6459-66; PMID:12444155; http://dx.doi.org/10.4049/jimmunol.169.11.6459
   PubMed Web of Science ®Google Scholar
• Gregory B, Kirchem A, Phipps S, Gevaert P, Pridgeon C, Rankin SM, Robinson DS. Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor α-chain expression by cytokines: IL-3, IL-5, and GM-CSF down-regulate IL-5 receptor α expression with loss of IL-5 responsiveness, but up-regulate IL-3 receptor α expression. J Immunol 2003; 170:5359-66; PMID:12759409; http://dx.doi.org/10.4049/jimmunol.170.11.5359
   PubMed Web of Science ®Google Scholar
• Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 2003; 167:199-204; PMID:12406833; http://dx.doi.org/10.1164/rccm.200208-789OC
   PubMed Web of Science ®Google Scholar
• Hart TK, Cook RM, Zia-Amirhosseini P, Minthorn E, Sellers TS, Maleeff BE, Eustis S, Schwartz LW, Tsui P, Appelbaum ER, et al. Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys. J Allergy Clin Immunol 2001; 108:250-7; PMID:11496242; http://dx.doi.org/10.1067/mai.2001.116576
   PubMed Web of Science ®Google Scholar
• Fulkerson PC, Rothenberg ME. Targeting eosinophils in allergy, inflammation and beyond. Nat Rev Drug Discov 2013; 12:117-29; PMID:23334207; http://dx.doi.org/10.1038/nrd3838
   PubMed Web of Science ®Google Scholar
• Kolbeck R, Kozhich A, Koike M, Peng L, Andersson CK, Damschroder MM, Reed JL, Woods R, Dall'acqua WW, Stephens GL, et al. MEDI-563, a humanized anti-IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity function. J Allergy Clin Immunol 2010; 125:1344-53 e2; PMID:20513525; http://dx.doi.org/10.1016/j.jaci.2010.04.004
   PubMed Web of Science ®Google Scholar
• Smith DA, Minthorn EA, Beerahee M. Pharmacokinetics and pharmacodynamics of mepolizumab, an anti-interleukin-5 monoclonal antibody. Clin Pharmacokinet 2011; 50:215-27; PMID:21348536; http://dx.doi.org/10.2165/11584340-000000000-00000
   PubMed Web of Science ®Google Scholar
• Gauvreau GM, Pageau R, Seguin R, Carballo D, Gauthier J, D'Anjou H, Campbell H, Watson R, Mistry M, Parry-Billings M, et al. Dose-response effects of TPI ASM8 in asthmatics after allergen. Allergy 2011; 66:1242-8; PMID:21605124; http://dx.doi.org/10.1111/j.1398-9995.2011.02638.x
   PubMed Web of Science ®Google Scholar
• Robb L, Drinkwater CC, Metcalf D, Li R, Kontgen F, Nicola NA, Begley CG. Hematopoietic and lung abnormalities in mice with a null mutation of the common β subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. Proc Natl Acad Sci USA 1995; 92:9565-9; PMID:7568173; http://dx.doi.org/10.1073/pnas.92.21.9565
   PubMed Web of Science ®Google Scholar
• Hercus TR, Bagley CJ, Cambareri B, Dottore M, Woodcock JM, Vadas MA, Shannon MF, Lopez AF. Specific human granulocyte-macrophage colony-stimulating factor antagonists. Proc Natl Acad Sci USA 1994; 91:5838-42; PMID:8016076; http://dx.doi.org/10.1073/pnas.91.13.5838
   PubMed Web of Science ®Google Scholar
• Hercus TR, Barry EF, Dottore M, McClure BJ, Webb AI, Lopez AF, Young IG, Murphy JM. High yield production of a soluble human interleukin-3 variant from E. coli with wild-type bioactivity and improved radiolabeling properties. PLoS One 2013; 8:e74376; PMID:23991218; http://dx.doi.org/10.1371/journal.pone.0074376
   PubMedGoogle Scholar
• Minter RR, Cohen ES, Wang B, Liang M, Vainshtein I, Rees G, Eghobamien L, Harrison P, Sims DA, Matthews C, et al. Protein engineering and preclinical development of a GM-CSF receptor antibody for the treatment of rheumatoid arthritis. Br J Pharmacol 2013; 168:200-11.
   PubMed Web of Science ®Google Scholar
• Kozak M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucl Acids Res 1987; 15:8125-48; PMID:3313277; http://dx.doi.org/10.1093/nar/15.20.8125
   PubMed Web of Science ®Google Scholar
• Koike M, Nakamura K, Furuya A, Iida A, Anazawa H, Takatsu K, Hanai N. Establishment of humanized anti-interleukin-5 receptor α chain monoclonal antibodies having a potent neutralizing activity. Hum Antibodies 2009; 18:17-27; PMID:19478395
   PubMedGoogle Scholar
• Spanevello MD, Tajouri SI, Mirciov C, Kurniawan N, Pearse MJ, Fabri LJ, Owczarek CM, Hardy MP, Bradford RA, Ramunno ML, et al. Acute delivery of EphA4-Fc improves functional recovery after contusive spinal cord injury in rats. J Neurotrauma 2013; 30:1023-34; PMID:23557244; http://dx.doi.org/10.1089/neu.2012.2729
   PubMed Web of Science ®Google Scholar
• Ritzen U, Rotticci-Mulder J, Stromberg P, Schmidt SR. Endotoxin reduction in monoclonal antibody preparations using arginine. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 856:343-7; PMID:17644450; http://dx.doi.org/10.1016/j.jchromb.2007.06.020
   PubMed Web of Science ®Google Scholar
• Hoet RM, Cohen EH, Kent RB, Rookey K, Schoonbroodt S, Hogan S, Rem L, Frans N, Daukandt M, Pieters H, et al. Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity. Nature Biotechnol 2005; 23:344-8; http://dx.doi.org/10.1038/nbt1067
   PubMed Web of Science ®Google Scholar
• Barbas CF, 3rd, Kang AS, Lerner RA, Benkovic SJ. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci USA 1991; 88:7978-82; PMID:1896445; http://dx.doi.org/10.1073/pnas.88.18.7978
   PubMed Web of Science ®Google Scholar
• Jostock T, Vanhove M, Brepoels E, Van Gool R, Daukandt M, Wehnert A, Van Hegelsom R, Dransfield D, Sexton D, Devlin M, et al. Rapid generation of functional human IgG antibodies derived from Fab-on-phage display libraries. J Immunol Methods 2004; 289:65-80; PMID:15251413; http://dx.doi.org/10.1016/j.jim.2004.03.014
   PubMed Web of Science ®Google Scholar
• Sidhu SS, Lowman HB, Cunningham BC, Wells JA. Phage display for selection of novel binding peptides. Methods Enzymol 2000; 328:333-63; PMID:11075354; http://dx.doi.org/10.1016/S0076-6879(00)28406-1
   PubMed Web of Science ®Google Scholar
• Kunkel TA, Roberts JD, Zakour RA. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol 1987; 154:367-82; PMID:3323813; http://dx.doi.org/10.1016/0076-6879(87)54085-X
   PubMed Web of Science ®Google Scholar
• McPhillips TM, McPhillips SE, Chiu HJ, Cohen AE, Deacon AM, Ellis PJ, Garman E, Gonzalez A, Sauter NK, Phizackerley RP, et al. Blu-Ice and the Distributed Control System: software for data acquisition and instrument control at macromolecular crystallography beamlines. J Synchrotron Radiat 2002; 9:401-6; PMID:12409628; http://dx.doi.org/10.1107/S0909049502015170
   PubMed Web of Science ®Google Scholar
• Kabsch W. Xds. Acta Crystallogr D Biol Crystallogr 2010; 66:125-32; PMID:20124692; http://dx.doi.org/10.1107/S0907444909047337
   PubMed Web of Science ®Google Scholar
• Evans PR, Murshudov GN. How good are my data and what is the resolution? Acta Crystallogr D Biol Crystallogr 2013; 69:1204-14; PMID:23793146; http://dx.doi.org/10.1107/S0907444913000061
   PubMed Web of Science ®Google Scholar
• McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. Phaser crystallographic software. J Appl Crystallogr 2007; 40:658-74; PMID:19461840; http://dx.doi.org/10.1107/S0021889807021206
   PubMed Web of Science ®Google Scholar
• Carr PD, Conlan F, Ford S, Ollis DL, Young IG. An improved resolution structure of the human β common receptor involved in IL-3, IL-5 and GM-CSF signalling which gives better definition of the high-affinity binding epitope. Acta Crystallogr Sect F Struct Biol Cryst Commun 2006; 62:509-13; PMID:16754968; http://dx.doi.org/10.1107/S1744309106016812
   PubMedGoogle Scholar
• Zhang H, Liu JH, Yang W, Springer T, Shimaoka M, Wang JH. Structural basis of activation-dependent binding of ligand-mimetic antibody AL-57 to integrin LFA-1. Proc Natl Acad Sci U S A 2009; 106:18345-50; PMID:19805116; http://dx.doi.org/10.1073/pnas.0909301106
   PubMed Web of Science ®Google Scholar
• Collaborative Computational Project N. The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 1994; 50:760-3; PMID:15299374; http://dx.doi.org/10.1107/S0907444994003112
   PubMed Web of Science ®Google Scholar
• Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 2010; 66:213-21; PMID:20124702; http://dx.doi.org/10.1107/S0907444909052925
   PubMed Web of Science ®Google Scholar
• Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 2004; 60:2126-32; PMID:15572765; http://dx.doi.org/10.1107/S0907444904019158
   PubMed Web of Science ®Google Scholar
• Chen VB, Arendall WB, 3rd, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 2010; 66:12-21; PMID:20057044; http://dx.doi.org/10.1107/S0907444909042073
   PubMed Web of Science ®Google Scholar
• Munson PJ, Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 1980; 107:220-39; PMID:6254391; http://dx.doi.org/10.1016/0003-2697(80)90515-1
   PubMed Web of Science ®Google Scholar
• O'Byrne PM, Dolovich J, Hargreave FE. Late asthmatic responses. Am Rev Resp Dis 1987; 136:740-51; PMID:3115156; http://dx.doi.org/10.1164/ajrccm/136.3.740
   PubMed Web of Science ®Google Scholar
• Wood LJ, Sehmi R, Gauvreau GM, Watson RM, Foley R, Denburg JA, O'byrne PM. An inhaled corticosteroid, budesonide, reduces baseline but not allergen-induced increases in bone marrow inflammatory cell progenitors in asthmatic subjects. Am J Respir Crit Care Med 1999; 159:1457-63; PMID:10228111; http://dx.doi.org/10.1164/ajrccm.159.5.9808123
   PubMed Web of Science ®Google Scholar
• Cyr MM, Baatjes AJ, Dorman SC, Crawford L, Sehmi R, Foley R, Alam R, Byrne PO, Denburg JA. In vitro effects of budesonide on eosinophil-basophil lineage commitment. Open Respir Med J 2008; 2:60-6; PMID:19343093; http://dx.doi.org/10.2174/1874306400802010060
   PubMedGoogle Scholar
• DeLano, W.L. 2002. DeLano Scientific (San Carlos, CA, USA). http://pymol.sourceforge.net/.
   Google Scholar